Interpace Biosciences, Inc. (IDXG)
1.73
-0.02
(-1.14%)
USD |
OTCM |
Mar 06, 09:29
Interpace Biosciences Cash from Investing (TTM) : -0.447M for Sept. 30, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| FONAR Corp. | -4.009M |
| Thermo Fisher Scientific, Inc. | -4.047B |
| XWELL, Inc. | 8.51M |
| Hypha Labs, Inc. | -0.0312M |
| Veracyte, Inc. | -9.209M |